Articles

The company says it is the pharmaceutical market’s first wet granulator with an integrated, truly continuous dryer.

L.B. Bohle Wet Granulator to Make US Debut at INTERPHEX

While this approval addresses breast cancer, olaparib in combination with durvalumab was approved by the EU in August 2024 for treatment of endometrial cancer.

Scottish Medicines Consortium Accepts AstraZeneca’s Breast Cancer Treatment

Feb. 11, 2025 marks the 10th anniversary of the International Day of Women and Girls in Science.

The 10th Anniversary of the International Day of Women and Girls in Science

In a lead up to The International Day of Women and Girls in Science, Pharmaceutical Technology® takes a look at the unique perspective women bring to the use of artificial intelligence in the pharmaceutical industry.

Women, STEM, and AI in Pharma

These infections can be caused by certain Gram-negative microorganisms, making the infections challenging to control due to high antimicrobial resistance.

FDA Approves AbbVie Treatment for Complicated Intra-Abdominal Infections

Felicity Thomas is the former Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Experts provide their insights into the trends that have shaped the global bio/pharma industry in 2024 and give their predictions as to what may be impactful in 2025 and beyond.

Industry Outlook 2025: Experts Weigh in on the Most Impactful Trends for Industry

Videos

Pharmaceutical Technology® sat down with Michelle Bridenbaker, COO of Unbiased Science, ahead of International Day of Women and Girls in Science to talk about the role of women in the pharmaceutical industry.

International Day of Women and Girls in Science: Support and Empowerment

Pharmaceutical Technology® sat down with Kate Coleman from Arriello to run through the major trends from 2024, including the importance of technological advances, and how these may progress in 2025.

Industry Outlook 2025: Regulating Technology for the Future

Cheryl Barton is director of PharmaVision, 

European biopharma companies are looking beyond GLP-1s.

Next-Generation Anti-Obesity Medicines

Installation was performed during the summer of 2024, and the system has already successfully completed its first production run for a leading biotech company.

News